Matthias Scheiner

461 total citations
13 papers, 357 citations indexed

About

Matthias Scheiner is a scholar working on Pharmacology, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Matthias Scheiner has authored 13 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 4 papers in Molecular Biology and 4 papers in Computational Theory and Mathematics. Recurrent topics in Matthias Scheiner's work include Cholinesterase and Neurodegenerative Diseases (11 papers), Computational Drug Discovery Methods (4 papers) and Alzheimer's disease research and treatments (3 papers). Matthias Scheiner is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (11 papers), Computational Drug Discovery Methods (4 papers) and Alzheimer's disease research and treatments (3 papers). Matthias Scheiner collaborates with scholars based in Germany, France and United States. Matthias Scheiner's co-authors include Michael Decker, Tangui Maurice, Matthias Hoffmann, Christoph Sotriffer, Sandra Gunesch, Barbara Monti, Feng He, Carina Stiller, Arnaud Chatonnet and C. James Chou and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Medicinal Chemistry.

In The Last Decade

Matthias Scheiner

13 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthias Scheiner Germany 9 235 129 123 80 73 13 357
Qinghong Liao China 11 201 0.9× 128 1.0× 188 1.5× 100 1.3× 44 0.6× 15 486
Baichen Xiong China 9 233 1.0× 157 1.2× 144 1.2× 89 1.1× 39 0.5× 13 450
Qihang Li China 12 229 1.0× 159 1.2× 157 1.3× 104 1.3× 22 0.3× 29 448
Samuele Maramai Italy 13 196 0.8× 104 0.8× 242 2.0× 116 1.4× 121 1.7× 29 512
Kamila Czarnecka Poland 14 173 0.7× 144 1.1× 142 1.2× 159 2.0× 38 0.5× 36 541
Sandra Gunesch Germany 9 216 0.9× 109 0.8× 146 1.2× 59 0.7× 38 0.5× 11 378
Rosa Purgatorio Italy 13 249 1.1× 149 1.2× 157 1.3× 292 3.6× 88 1.2× 39 637
Martín Estrada Spain 14 276 1.2× 155 1.2× 162 1.3× 198 2.5× 58 0.8× 21 500
Akash Marathakam India 10 126 0.5× 61 0.5× 121 1.0× 97 1.2× 20 0.3× 19 381
Mariana P. Arce Spain 10 350 1.5× 203 1.6× 152 1.2× 218 2.7× 41 0.6× 15 526

Countries citing papers authored by Matthias Scheiner

Since Specialization
Citations

This map shows the geographic impact of Matthias Scheiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Scheiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Scheiner more than expected).

Fields of papers citing papers by Matthias Scheiner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Scheiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Scheiner. The network helps show where Matthias Scheiner may publish in the future.

Co-authorship network of co-authors of Matthias Scheiner

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Scheiner. A scholar is included among the top collaborators of Matthias Scheiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Scheiner. Matthias Scheiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Scheiner, Matthias, et al.. (2025). Total Syntheses of the Amaryllidaceae Alkaloids Carltonines A–C and the Neuroprotective and Immunomodulatory Evaluation of Carltonine B. Journal of Natural Products. 88(10). 2460–2471. 1 indexed citations
2.
Hoffmann, Matthias, Matthias Scheiner, Lucie Crouzier, et al.. (2024). The selective butyrylcholinesterase inhibitor UW‐MD‐95 shows symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer's disease. CNS Neuroscience & Therapeutics. 30(6). e14814–e14814. 8 indexed citations
4.
5.
Scheiner, Matthias, Axel Zeeck, Tilmann Weber, et al.. (2021). The Structure of Cyclodecatriene Collinolactone, its Biosynthesis, and Semisynthetic Analogues: Effects of Monoastral Phenotype and Protection from Intracellular Oxidative Stress. Angewandte Chemie International Edition. 60(43). 23212–23216. 7 indexed citations
6.
He, Feng, C. James Chou, Matthias Scheiner, et al.. (2021). Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model. Journal of Medicinal Chemistry. 64(7). 3794–3812. 49 indexed citations
7.
Hofmann, Julian, Tiziana Ginex, Alba Espargaró, et al.. (2021). Azobioisosteres of Curcumin with Pronounced Activity against Amyloid Aggregation, Intracellular Oxidative Stress, and Neuroinflammation. Chemistry - A European Journal. 27(19). 6015–6027. 5 indexed citations
8.
Hofmann, Julian, Shaimaa Fayez, Matthias Scheiner, et al.. (2020). Sterubin: Enantioresolution and Configurational Stability, Enantiomeric Purity in Nature, and Neuroprotective Activity in Vitro and in Vivo. Chemistry - A European Journal. 26(32). 7299–7308. 27 indexed citations
9.
Scheiner, Matthias, et al.. (2020). Photopharmacology on Acetylcholinesterase: Novel Photoswitchable Inhibitors with Improved Pharmacological Profiles. ChemPhotoChem. 5(2). 149–159. 19 indexed citations
10.
Scheiner, Matthias, Sandra Gunesch, Matthias Hoffmann, et al.. (2019). Dual-Acting Cholinesterase–Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo. Journal of Medicinal Chemistry. 62(20). 9078–9102. 39 indexed citations
11.
Scheiner, Matthias, et al.. (2019). Multi-target-directed-ligands acting as enzyme inhibitors and receptor ligands. European Journal of Medicinal Chemistry. 180. 690–706. 31 indexed citations
12.
Hoffmann, Matthias, Carina Stiller, Matthias Scheiner, et al.. (2019). Highly Selective Butyrylcholinesterase Inhibitors with Tunable Duration of Action by Chemical Modification of Transferable Carbamate Units Exhibit Pronounced Neuroprotective Effect in an Alzheimer’s Disease Mouse Model. Journal of Medicinal Chemistry. 62(20). 9116–9140. 70 indexed citations
13.
Scheiner, Matthias, Jacqueline Ramler, Christoph Sotriffer, et al.. (2015). Aminobenzimidazoles and Structural Isomers as Templates for Dual‐Acting Butyrylcholinesterase Inhibitors and hCB2R Ligands To Combat Neurodegenerative Disorders. ChemMedChem. 11(12). 1270–1283. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026